FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)

View source ↗

Summary

The FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) submitted by H2-Pharma LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ZYPREXA RELPREVV (olanzapine pamoate)

Snippet

SUPPL AP for ZYPREXA RELPREVV (OLANZAPINE PAMOATE)